Last reviewed · How we verify
Commercial ibuprofen
Ibuprofen inhibits cyclooxygenase (COX) enzymes to reduce the production of prostaglandins, thereby decreasing inflammation, pain, and fever.
Ibuprofen inhibits cyclooxygenase (COX) enzymes to reduce the production of prostaglandins, thereby decreasing inflammation, pain, and fever. Used for Mild to moderate pain, Fever reduction, Inflammation associated with headache, muscular aches, backache, minor arthritis pain, menstrual cramps, and common cold.
At a glance
| Generic name | Commercial ibuprofen |
|---|---|
| Also known as | Commercial IBU |
| Sponsor | Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division |
| Drug class | Nonsteroidal anti-inflammatory drug (NSAID) |
| Target | Cyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2) |
| Modality | Small molecule |
| Therapeutic area | Pain Management, Inflammation, Fever |
| Phase | Phase 3 |
Mechanism of action
Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that non-selectively blocks COX-1 and COX-2 enzymes, which catalyze prostaglandin synthesis. By reducing prostaglandin levels in tissues, it suppresses inflammatory responses, alleviates pain signaling, and lowers body temperature set point. This mechanism makes it effective for mild to moderate pain and inflammatory conditions.
Approved indications
- Mild to moderate pain
- Fever reduction
- Inflammation associated with headache, muscular aches, backache, minor arthritis pain, menstrual cramps, and common cold
Common side effects
- Gastrointestinal upset (nausea, dyspepsia, abdominal pain)
- Heartburn
- Dizziness
- Rash
- Gastrointestinal bleeding (with chronic use)
- Cardiovascular events (with chronic use)
Key clinical trials
- Study of Acetaminophen (ACM) in Post-operative Dental Pain (PHASE3)
- Study of Acetaminophen (ACE) in Post-operative Dental Pain (PHASE2)
- Randomized, Double-Blind, Single-Dose, Efficacy and Safety Study of Test Acetaminophen Tablet in Postoperative Dental Pain (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |